13THERAPEUTICS
13Therapeutics, Inc is a spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis. U.S. patents claiming the composition of the lead peptide and its use in all inflammatory conditions involving Toll-Like Receptor (TLR) signaling have been issued, and several additional patents have been issued. The company performs all in vitro testing in-house and subcontracts with OHSU and other academic instututions for animal model testing. The company is privately funded and has received NIH peer reviewed grants, including multiple Phase II and Phase II SBIR grants.
13THERAPEUTICS
Industry:
Health Care
Founded:
2008-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.13therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(503)525-4887
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Mobile Non Scaleable Content Microsoft Exchange Online Amazon Organization Schema Office 365 Mail Google Maps
Current Employees Featured
Founder
Investors List
NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) investment in Grant - 13Therapeutics
Official Site Inspections
http://www.13therapeutics.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "13Therapeutics"
Company
13Therapeutics, Inc is a spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis. The company performs all in vitro testing in-house and subcontracts with OHSU …See details»
13Therapeutics - Crunchbase Company Profile & Funding
13Therapeutics, Inc is a spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis. U.S. patents claiming the composition of …See details»
Management - 13therapeutics, Inc
Steven H. Hefeneider, Ph.D. is an Immunologist by training with a focus on immune regulation and Founder of 13therapeutics, Inc. Dr. Hefeneider serves as the company's CEO/President and is the co-inventor of the P13 peptide and …See details»
13therapeutics - LinkedIn
13therapeutics is a research and drug development company identifying and characterizing novel anti-inflammatory peptide therapeutics for unmet medical needs with high commercial potential.See details»
13Therapeutics 2025 Company Profile: Valuation, Funding
Information on valuation, funding, acquisitions, investors, and executives for 13Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
13Therapeutics - Funding, Financials, Valuation & Investors
13Therapeutics is funded by NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR).See details»
13therapeutics - Craft
13therapeutics is a research and drug development company identifying and characterizing anti-inflammatory peptide therapeutics. It develops a platform for discovering peptides derived from …See details»
13THERAPEUTICS, INC. - VentureRadar
13THERAPEUTICS, INC. VentureRadar profile. Find out more about 13THERAPEUTICS, INC., Peptide Therapeutics, Peptides, DNA, RNA and Peptide Therapies and .See details»
13therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Explore 13therapeutics with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Small molecule ...See details»
13therapeutics, Inc. - Overview, News & Similar companies
View 13therapeutics, Inc. (www.13therapeutics.com) location in Oregon, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
13Therapeutics - Contacts, Employees, Board Members, Advisors …
13Therapeutics has 2 current employee profiles, including Vice-President of Product Development and Director of Research Sharon McCoy.See details»
13therapeutics Overview | SignalHire Company Profile
13therapeutics is a research and drug development company identifying and characterizing novel anti-inflammatory peptide therapeutics for unmet medical needs with high commercial …See details»
13THERAPEUTICS, INC. Employer Identification Number EIN
13THERAPEUTICS, INC. is a USA domiciled entity or foreign entity operating in the USA. The EIN ihas been issued by the IRSSee details»
13therapeutics - Products, Competitors, Financials, Employees ...
13therapeutics is a biotechnology company focused on the research and development of novel anti-inflammatory peptide therapeutics. The company specializes in creating peptides that …See details»
Board of Directors - 13therapeutics, Inc
Steven H. Hefeneider, Ph.D. is an immunologist by training with a focus on immune regulation and Founder of 13therapeutics, Inc. Dr. Hefeneider serves as the company's CEO/President …See details»
13therapeutics, Inc. Company Profile | Management and
13therapeutics, Inc. Profile and History Founded in 2008, 13therapeutics is headquartered in Portland, Oregon. They are a research and drug development company that identify, …See details»
Science - 13therapeutics, Inc
The company's peptides have mechanisms of action that are distinct from steroids and NSAIDs and have potential application for treatment of both acute and chronic inflammatory diseases. …See details»
13therapeutics - Regenerative Medicine Now
13therapeutics, Inc is a research and drug development company identifying, characterizing, and optimizing novel anti-inflammatory peptide therapeutics for unmet medical needs with high …See details»
TRIP13 protects pancreatic cancer cells against intrinsic and …
Oncogene activation in normal untransformed cells induces DNA replication stress and creates a dependency on DNA damage response (DDR) mechanisms for cell survival. Different …See details»
Scientific Advisory Board - 13therapeutics, Inc
She also received a grant from the National Organization for Hearing Research (NOHR) in 2011 to study the genetic variation in the immune system to otitis media. She collaborates with an …See details»